The Wall Street Journal5d agoneutral
Health Care Roundup: Market TalkFind insight on the deal between Hengrui Pharmaceuticals and Bristol Myers Squibb and more in the latest Market Talks covering the health care sector.
Notícias
Apenas manchetes de alto sinal — eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
48last 24h
1673last 7d
313🟢 bullish (7d)
171🔴 bearish (7d)
136publishers
The Wall Street Journal5d agoneutral
Bristol-Myers Squibb and China’s Hengrui Pharma Forge Tie-UpU.S. pharma giant Bristol-Myers Squibb has struck a partnership and licensing deal with Chinese drugmaker Hengrui, in a deal that could worth more than $15 billion.
